Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.
- DOI
- 10.1016/j.biopha.2026.119908
- Published
- 2026 Oct
- Container
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119908,
title = {Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.},
author = {Obeid K and Konijnenberg M and Bezverkhniaia E and Maina T and Nock BA and Tolmachev V and Kanellopoulos P and Orlova A},
year = {2026},
journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
doi = {10.1016/j.biopha.2026.119908},
url = {https://doi.org/10.1016/j.biopha.2026.119908}
}RIS
TY - JOUR TI - Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing. AU - Obeid K AU - Konijnenberg M AU - Bezverkhniaia E AU - Maina T AU - Nock BA AU - Tolmachev V AU - Kanellopoulos P AU - Orlova A PY - 2026 JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie DO - 10.1016/j.biopha.2026.119908 UR - https://doi.org/10.1016/j.biopha.2026.119908 ER -
APA
K, O., M, K., E, B., T, M., BA, N., V, T., P, K., & A, O. (2026). Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119908
Source records
- pubmed · retrieved 2026-09-25T22:24:44.827Z